REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 1.750% 2/1
Principal, excl. options Q1 2024
233 M
Holdings value Q1 2024
$203 M
Value change Q1 2024
-$23.1 B
Grand Portfolio weight change Q1 2024
-0.048%
Number of holders
22
Number of buys Q1 2024
9
Number of sells Q1 2024
-9
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.241%
CUSIP
761330AB5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $233 M $203 M -$23.1 B $0.73 22
2023 Q4 $261 M $189 M +$5.83 M $0.76 22
2023 Q3 $255 M $1.33 B +$1.15 B $0.80 29
2023 Q2 $229 M $243 M -$15.2 M $1.06 26
2023 Q1 $238 M $298 M -$2.93 B $1.23 26
2022 Q4 $189 M $175 M -$32 M $0.92 21
2022 Q3 $230 M $251 M -$7.33 M $1.09 24
2022 Q2 $236 M $194 M -$15.2 M $0.81 16
2022 Q1 $249 M $237 M -$22 M $0.94 18
2021 Q4 $246 M $222 M -$14.7 M $0.88 17
2021 Q3 $282 M $332 M +$6.89 M $1.15 21
2021 Q2 $262 M $330 M +$1.16 M $1.17 25
2021 Q1 $266 M $327 M +$327 M $1.12 27